Most recently, Dr Amaral was President and CEO of Rhode Island Hospital (RIH) and its pediatric division Hasbro Children’s Hospital from 2000 to 20007 and also served as its COO for 3 1/2 years. During this period, he led a financial turnaround while at the same time investing over $450 million in renovation projects, new technologies and new facilities and tripling externally funded research.
Dr Amaral was instrumental in the success of Ultracision, a start-up company, by developing the company CEO Tom Davison, Ph.D., the Harmonic Scalpel, the first and still leading ultrasonically activated cutting and coagulating surgical device. He has served as a consultant, advisory board member and board member to multiple leading healthcare biotech and start-up companies.
He is Professor of Surgery at Brown University School of Medicine, member of 25+ professional societies, author of 80+ papers and book chapters and has delivered 250+ national and international presentations.
Dr Amaral will be discussing 'Clicnical Trials to
Reimbursement' as part of one of our workshops on Day Three.
